Catalytic hydrolysis of VIP in pregnant women with asthma

Journal of Asthma

Volumn 43, Issue 6, 2006, Pages 429-432

  Olopade, Christopher O ^a   Yu, John ^a   Abubaker, Jawed ^a   Mensah, Edward ^a   Paul, Sudhir ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Asthma; Catalytic autoantibody; Pregnancy; Vasoactive intestinal peptide

Indexed keywords

AUTOANTIBODY; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; IMMUNOGLOBULIN ANTIBODY; PREDNISONE; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADULT; ARTICLE; ASTHMA; CATALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYDROLYSIS; PREGNANCY;

ADULT; ASTHMA; AUTOANTIBODIES; CATALYSIS; FEMALE; HUMANS; HYDROLYSIS; IMMUNOGLOBULIN G; PREGNANCY; PREGNANCY COMPLICATIONS; PROSPECTIVE STUDIES; VASOACTIVE INTESTINAL PEPTIDE;

EID: 33748441930     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1080/02770900600710730     Document Type: Article

References (29)

1. Barnes P, Dixon CM. The effect of inhaled vasoactive intestinal peptide on bronchial reactivity to histamine in humans. Am Rev Respir Dis 1984; 130:162-166.
2. Said S. Vasoactive intestinal peptides in the lung, with special reference to vasoactive intestinal peptide. Exp Lung Res 1982; 3:343-348.
3. Dorsam G, Voice J, Kong Y, Goetzl EJ. Vasoactive intestinal peptide mediations of development and functions of T lymphocytes. Ann NY Acad Sci 2000; 921:79-91.
4. Ganea D. Regulatory effects of vasoactive intestinal peptide on cytokine production in central and peripheral lymphoid organs. Adv Neuroimmunol 1996; 6:61-74.
5. Berisha H, Bratut M, Bangale Y, Colasurdo G, Paul S, Said S. New Evidence for transmitter role of VIP in the airways: impaired relaxation by a catalytic antibody. Pulm Pharmacol Ther 2002; 15:121-127.
6. Paul S, Said SI, Thompson AB, Volle DJ, Agrawal DK, Foda H, de La Rocha S. Characterization of autoantibodies to vasoactive intestinal peptide in asthma. J Neuroimmunol 1989; 23:133-142.
7. Bangale Y, Cavill D, Gordon T, Planque S, Taguchi H, Bhatia G, Nishiyama Y, Arnett F, Paul S. Vasoactive intestinal peptide binding autoantibodies in autoimmune humans and mice. Peptides 2002; 12:2251-2257.
8. Mestman J. Hyperthyroidism in pregnancy. Clin Obstet Gynecol 1997; 40:45-64.
9. Bebo B Jr. Evidence that pregnancy specific glycoproteins regulate T-cell function and inflammatory auto-immune disease during pregnancy. Curr Drug Targets Inflamm Allergy 2005; 4:231-237.
10. Lakasing L, Williamson C. Obstetric complications due to autoantibodies. Best Pract Res Clini Endocrinol 2005; 19:149-175.
11. Gluck J. The change of asthma course during pregnancy. Clin Rev Allergy Immunol 2004; 26:171-180.
12. Turner E, Greenberger PA, Patterson R. Management of the pregnant asthmatic patient. Ann Intern Med 1980; 93:905.
13. Paul S, Mei S, Mody B, Eklund SH, Beach CM, Massey RJ, Hamel F. Cleavage of vasoactive intestinal peptide at multiple sites by autoantibodies. J Biol Chem 1991; 266:16128-16134.
14. Samuels ML, Witmer JA. Statistics for life sciences. 2003; 290-293.
15. Gao Q, Sun M, Tyutyulkova S, Webster D, Rees A, Tramontano A, Massey RJ, Paul S. Molecular cloning of a proteolytic antibody light chain. J Biol Chem 1994; 269:32389-32393.
16. Tyutyulkova S, Gao QS, Thompson A, Rennard S, Paul S. Efficient vasoactive intestinal polypeptide hydrolyzing autoantibody light chains selected by phage display. Biochem Biophys Acta 1996; 1316:217-223.
17. Ghatei M, Sheppard MN, O'Shaughnessy DJ, Adrian TE, McGregor GP, Polak JM, Bloom SR. Regulatory peptides in the mammalian respiratory tract. Endocrinology 1982; 111:1248-1254.
18. Said S, Rattan S. The Multiple mediators of neurogenic smooth muscle relaxation. Trends Endocrinol Metab 2004; 15:189-191.
19. Fischer A, Hoffman B, Nitric oxide synthase in neurons and nerves of lower airways and in vagal sensory ganglia of man. Correlation with neuropeptides. Am J Respir Crit Care 1996; 154:209-216.
20. Hasaneen N, Foda HD, Said SI. Nitric oxide and vasoactive intestinal peptide as co-transmitters of airway smooth muscle relaxation. Analysis in neuronal nitric oxide synthase knockout mice. Chest 2003; 124:1067-1072.
21. Huizinga J, Tomlinson J, Pintin-Quezada J. Involvement of nitric oxide in nerve-mediated inhibition and action of vasoactive intestinal peptide in colonic smooth muscle. J Pharmacol Exp Ther 1992; 260:803-808.
22. Spessart R. Vasoactive intestinal peptide stimulation of cyclic monophosphate formation: Further evidence for a role of nitric oxide synthase and cytosolic guanylate cyclase in rat pineolocytes. Endocrinology 1993; 132:2513-2517.
23. Nio D, Moylan RN, Roche JK. Modulation of T lymphocyte function by neuropeptides. Evidence for their role as local immunoregulatory elements. J Immunol 1993; 150:5281-5288.
24. Groneberg D, Fischer A. Vasoactive intestinal peptide as mediator of asthma. Pulmonary Pharmacol Therapeutics 2001; 14:391-401.
25. Ollerewnshaw S, Jarvis D, Woolcock A, Sullivan C, Scheiber T. Absence of immunoreactive vasoactive intestinal peptide in tissue from the lungs of patients with asthma. N Engl J Med 1989; 320:1244-1248.
26. Chanez P, Springall D, Vignola AM, Moradoghi-Hattvani A, Polak JM, Godard P, Bousquet J. Bronchial mucosal immunoreactivity of sensory neuropeptides in severe airway disease. Am J Respir Crit Care 1998; 158:985-990.
27. Ohzeki T, Ishitani N, Hanaki K, Motozumi H, Ohtahara H, Fukushima K, Nakai S, Kishida M, Kobayashi S, Shiraki K. Response of plasma vasoactive intestinal polypeptide to metacholine and exercise loading in children and adolescents with bronchial asthma. Pediatr Allergy Immunol 1993; 4:26-29.
28. Linden A, Hansson L, Anderson A, Palmqvist M, Arvidsson P. Lofdahl CG, Larsson P. Bronchodilation by an inhaled VPAC2 receptor agonist in patients with stable asthma. Thorax 2003; 58:217-221.
29. Voice J, Grinninger C, Kong Y, Bangale Y, Paul S, Goetzl EJ. Roles of vasoactive intestinal peptide (VIP) in the expression of different immune phenotypes by wild-type mice and T cell-targeted type II VIP receptor transgenic mice. J Immunol 2003; 170:308-314.